Incyte (INCY) EBIT (2010 - 2026)
Incyte's (INCY) quarterly EBIT came in at $697.9 million in Q2 2026, up 31.6% YoY from $530.3 million in Q2 2025, and up 131.77% on a QoQ basis from $301.1 million in Q1 2026.
Incyte (INCY) EBIT (2010 - 2026) Analysis & Trends
Incyte (INCY) has 17 years of EBIT data on file, last reported at $697.9 million in Q2 2026.
- Quarterly EBIT rose 31.6% year-over-year to $697.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (up 50.32% YoY) and the FY2025 annual result came in at $1.5 billion, up 2368.56% from the prior year.
- EBIT grew to $697.9 million in Q2 2026, from $301.1 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $697.9 million in Q2 2026 to a low of -$478.1 million in Q2 2024.
- A 5-year average of $209.7 million and a median of $199.5 million in 2023 frame the typical range for EBIT.
- The widest YoY moves for EBIT: up 271.01% in 2024, down 346.74% in 2024.
- Tracing INCY's EBIT over 5 years: stood at $70.1 million in 2022, then surged by 167.17% to $187.3 million in 2023, then surged by 61.0% to $301.5 million in 2024, then advanced by 11.39% to $335.9 million in 2025, then surged by 107.79% to $697.9 million in 2026.
- The last three EBIT figures came in at $697.9 million (Q2 2026), $301.1 million (Q1 2026), and $335.9 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Incyte | 24.15 Bn | 19.61 Bn | 1.57 Bn | 697.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 697.90 Mn |
| Mar 31, 2026 | 301.12 Mn |
| Dec 31, 2025 | 335.86 Mn |
| Sep 30, 2025 | 443.52 Mn |
| Jun 30, 2025 | 530.31 Mn |
| Mar 31, 2025 | 205.17 Mn |
| Dec 31, 2024 | 301.51 Mn |
| Sep 30, 2024 | 146.09 Mn |
| Jun 30, 2024 | -478.13 Mn |
| Mar 31, 2024 | 91.90 Mn |
| Dec 31, 2023 | 187.27 Mn |
| Sep 30, 2023 | 214.71 Mn |
| Jun 30, 2023 | 193.78 Mn |
| Mar 31, 2023 | 24.77 Mn |
| Dec 31, 2022 | 70.09 Mn |
| Sep 30, 2022 | 138.38 Mn |
| Jun 30, 2022 | 254.43 Mn |
| Mar 31, 2022 | 116.54 Mn |
| Dec 31, 2021 | 110.73 Mn |
| Sep 30, 2021 | 235.41 Mn |